Canada - English - Health Canada

ratiopharm inc division of teva canada limited - beclomethasone dipropionate - spray - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

Canada - English - Health Canada

altimed pharma inc. - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - adrenals

Canada - English - Health Canada

prempharm inc - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - corticosteroids

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar ® is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. important limitations of use: - qvar is not indicated for the relief of acute bronchospasm. 4.1 status asthmaticus qvar is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. 4.2 hypersensitivity qvar is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar [see warnings and precautions ( 5.6)]. risk summary there are no adequate and well-controlled studies with qvar or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases in congenital malformations or othe

United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. important limitations of use: - qvar redihaler is not indicated for the relief of acute bronchospasm. qvar redihaler is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . qvar redihaler is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

orient europharma (m) sdn bhd - beclomethasone dipropionate; formoterol fumarate dihydrate; glycopyrronium bromide -

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875-00100 nairobi - beclomethasone dipropionate /clotrimazole - cream - beclomethasone dipropionate0.025%w/w/clotrimazole… - other combinations of potent corticosteroids for